DaVita Inc. (DVA)
NYSE: DVA · IEX Real-Time Price · USD
134.45
-7.79 (-5.48%)
At close: May 3, 2024, 4:00 PM
134.16
-0.29 (-0.22%)
After-hours: May 3, 2024, 7:33 PM EDT
DaVita Revenue
DaVita had revenue of $12.34B in the twelve months ending March 31, 2024, with 5.77% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.07B with 6.89% year-over-year growth. In the year 2023, DaVita had annual revenue of $12.14B with 4.57% growth.
Revenue (ttm)
$12.34B
Revenue Growth
+5.77%
P/S Ratio
0.96
Revenue / Employee
$176,257
Employees
70,000
Market Cap
11.79B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
Dec 31, 2019 | 11.39B | -16.37M | -0.14% |
Dec 31, 2018 | 11.40B | 528.22M | 4.86% |
Dec 31, 2017 | 10.88B | 169.17M | 1.58% |
Dec 31, 2016 | 10.71B | 725.22M | 7.27% |
Dec 31, 2015 | 9.98B | -2.81B | -21.98% |
Dec 31, 2014 | 12.80B | 1.03B | 8.76% |
Dec 31, 2013 | 11.76B | 3.58B | 43.70% |
Dec 31, 2012 | 8.19B | 1.45B | 21.61% |
Dec 31, 2011 | 6.73B | 512.20M | 8.24% |
Dec 31, 2010 | 6.22B | 118.96M | 1.95% |
Dec 31, 2009 | 6.10B | 440.48M | 7.78% |
Dec 31, 2008 | 5.66B | 396.02M | 7.52% |
Dec 31, 2007 | 5.26B | 383.49M | 7.86% |
Dec 31, 2006 | 4.88B | 1.91B | 64.12% |
Dec 31, 2005 | 2.97B | 796.59M | 36.59% |
Dec 31, 2004 | 2.18B | 258.05M | 13.45% |
Dec 31, 2003 | 1.92B | 64.65M | 3.49% |
Dec 31, 2002 | 1.85B | 203.88M | 12.35% |
Dec 31, 2001 | 1.65B | 164.45M | 11.06% |
Dec 31, 2000 | 1.49B | 40.95M | 2.83% |
Dec 31, 1999 | 1.45B | 241.61M | 20.07% |
Dec 31, 1998 | 1.20B | 445.34M | 58.72% |
Dec 31, 1997 | 758.40M | 261.75M | 52.70% |
Dec 31, 1996 | 496.65M | 282.23M | 131.62% |
May 31, 1995 | 214.43M | 92.36M | 75.66% |
May 31, 1994 | 122.07M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.91B |
Solventum | 8.20B |
Charles River Laboratories International | 4.13B |
Incyte | 3.77B |
Exact Sciences | 2.50B |
United Therapeutics | 2.50B |
Medpace Holdings | 1.96B |
Insulet | 1.70B |
DVA News
- 1 day ago - DaVita gains after upbeat quarterly profit prompts annual forecast raise - Reuters
- 1 day ago - DaVita Inc. 1st Quarter 2024 Results - PRNewsWire
- 9 days ago - Best blue chip healthcare stocks to buy and hold in 2024 - Invezz
- 12 days ago - DaVita's Global Operations Powered by 100% Renewable Energy - PRNewsWire
- 16 days ago - DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call - PRNewsWire
- 24 days ago - DaVita Announces Dennis Pullin to its Board of Directors - PRNewsWire
- 7 weeks ago - The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On - PRNewsWire
- 2 months ago - DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024 - PRNewsWire